Cargando…
1107. Third Generation Cephalosporins Monotherapy Experience in Pediatric Patients with High-Risk Febrile Neutropenia
BACKGROUND: Fever during neutropenia is common in children with cancer. The updated guidelines recommend empirical antibiotic monotherapy using an antipseudomonal ß-lactam, a fourth generation cephalosporin or a carbapenem for high-risk febrile neutropenia. However, local epidemiology and resistance...
Autores principales: | Gutierrez, Valentina, Claverie, Ximena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776825/ http://dx.doi.org/10.1093/ofid/ofaa439.1293 |
Ejemplares similares
-
203. Opportunities for Antimicrobial Stewardship in Febrile Neutropenia
por: Shoff, Christopher, et al.
Publicado: (2020) -
242. Comprehensive Pathogen Detection for Pediatric Febrile Neutropenia by Metagenomic Next-Generation Sequencing
por: Horiba, Kazuhiro, et al.
Publicado: (2019) -
1550. Pediatric Febrile Neutropenia: Does Depth and Duration of Neutropenia at Presentation Predict Outcomes?
por: Alali, Muayad, et al.
Publicado: (2018) -
92. Utility of Sinus CT in the Evaluation of Patients with Febrile Neutropenia
por: Gurram, Pooja, et al.
Publicado: (2020) -
1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)